• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病所致心力衰竭负担的全球趋势与差异:2021年全球疾病负担研究分析

Global trends and disparities in the burden of heart failure caused by chronic kidney disease: an analysis of the global burden of disease study 2021.

作者信息

Ye Lingxia, Huang Xin, Xu Yufeng

机构信息

Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

Department of Endocrinology and Metabolism, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui Municipal Central Hospital, Lishui, China.

出版信息

Front Med (Lausanne). 2025 Apr 17;12:1567128. doi: 10.3389/fmed.2025.1567128. eCollection 2025.

DOI:10.3389/fmed.2025.1567128
PMID:40313544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12043581/
Abstract

BACKGROUND

Heart failure (HF) is a major public health concern, and chronic kidney disease (CKD) plays a significant role in its pathogenesis. Understanding the trends and disparities in the burden of HF caused by CKD can provide valuable insights into health policymaking.

METHODS

This study was a secondary analysis based on previously published data. We obtained global, regional, national, and age- and sex-specific data on the prevalence and years lived with disability (YLDs) of HF caused by CKD from the Global Burden of Disease Study 2021 (GBD 2021) and performed a secondary comparative analysis by age, sex, time, location, sociodemographic index (SDI), and health system level.

RESULTS

In 2021, there were 1,936.9 (95%UI: 1,600.2-2,343.5) thousand cases of HF caused by CKD globally, with an age-standardized rate of YLDs of 3.1 (95%UI: 1.9-4.4) per 100,000 population. The global burden of HF caused by CKD has continuously increased from 1990 to 2021 and is expected to keep growing through 2045 according to predictions. Significant disparities were found across different locations, genders, and ages. Higher burdens were noted among males, older individuals, and regions with lower SDI or less advanced health systems.

CONCLUSION

The burden of HF caused by CKD has increased significantly since 1990 and varies widely across regions. More significant efforts are needed in the prevention and treatment of CKD and HF, especially among older individuals and males in regions with lower SDI or less advanced health systems.

摘要

背景

心力衰竭(HF)是一个重大的公共卫生问题,慢性肾脏病(CKD)在其发病机制中起重要作用。了解由CKD导致的HF负担的趋势和差异可为卫生政策制定提供有价值的见解。

方法

本研究是基于先前发表的数据进行的二次分析。我们从《2021年全球疾病负担研究》(GBD 2021)中获取了关于由CKD导致的HF的患病率和残疾生活年数(YLDs)的全球、区域、国家以及年龄和性别特异性数据,并按年龄、性别、时间、地点、社会人口指数(SDI)和卫生系统水平进行了二次比较分析。

结果

2021年,全球由CKD导致的HF病例有193.69万例(95%不确定区间:160.02万 - 234.35万例),年龄标准化的YLDs率为每10万人3.1例(95%不确定区间:1.9 - 4.4例)。从1990年到2021年,由CKD导致的HF的全球负担持续增加,根据预测,到2045年预计还将继续增长。在不同地点、性别和年龄之间发现了显著差异。男性、老年人以及SDI较低或卫生系统较不发达地区的负担更高。

结论

自1990年以来,由CKD导致的HF负担显著增加,且地区差异很大。在CKD和HF的预防和治疗方面需要做出更大努力,特别是在SDI较低或卫生系统较不发达地区的老年人和男性中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f44/12043581/bac610385105/fmed-12-1567128-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f44/12043581/443f4468569a/fmed-12-1567128-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f44/12043581/44e2bd8f37e5/fmed-12-1567128-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f44/12043581/18ae6241096c/fmed-12-1567128-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f44/12043581/bac610385105/fmed-12-1567128-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f44/12043581/443f4468569a/fmed-12-1567128-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f44/12043581/44e2bd8f37e5/fmed-12-1567128-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f44/12043581/18ae6241096c/fmed-12-1567128-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f44/12043581/bac610385105/fmed-12-1567128-g004.jpg

相似文献

1
Global trends and disparities in the burden of heart failure caused by chronic kidney disease: an analysis of the global burden of disease study 2021.慢性肾脏病所致心力衰竭负担的全球趋势与差异:2021年全球疾病负担研究分析
Front Med (Lausanne). 2025 Apr 17;12:1567128. doi: 10.3389/fmed.2025.1567128. eCollection 2025.
2
Global, regional, and national burdens of heart failure in adolescents and young adults aged 10-24 years from 1990 to 2021: an analysis of data from the Global Burden of Disease Study 2021.1990年至2021年10至24岁青少年和青年人心力衰竭的全球、区域和国家负担:基于2021年全球疾病负担研究数据的分析
EClinicalMedicine. 2024 Dec 9;79:102998. doi: 10.1016/j.eclinm.2024.102998. eCollection 2025 Jan.
3
Global, regional, and national burden of heart failure and its underlying causes, 1990-2021: results from the global burden of disease study 2021.1990-2021年全球、区域和国家心力衰竭及其潜在病因的负担:全球疾病负担研究2021年结果
Biomark Res. 2025 Jan 23;13(1):16. doi: 10.1186/s40364-025-00728-8.
4
Global trends in heart failure from 1990 to 2019: An age-period-cohort analysis from the Global Burden of Disease study.2019 年全球心力衰竭趋势:来自全球疾病负担研究的年龄-时期-队列分析。
ESC Heart Fail. 2024 Oct;11(5):3264-3278. doi: 10.1002/ehf2.14915. Epub 2024 Jun 27.
5
Global, regional, and national burden of chronic kidney disease attributable to high sodium intake from 1990 to 2019.1990年至2019年全球、区域和国家因高钠摄入导致的慢性肾脏病负担
Front Nutr. 2023 Mar 2;10:1078371. doi: 10.3389/fnut.2023.1078371. eCollection 2023.
6
What was the Epidemiology and Global Burden of Disease of Hip Fractures From 1990 to 2019? Results From and Additional Analysis of the Global Burden of Disease Study 2019.1990 年至 2019 年髋部骨折的流行病学和全球疾病负担是怎样的?来自 2019 年全球疾病负担研究的结果及进一步分析。
Clin Orthop Relat Res. 2023 Jun 1;481(6):1209-1220. doi: 10.1097/CORR.0000000000002465. Epub 2022 Nov 2.
7
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
8
Trends and disparities in disease burden of age-related macular degeneration from 1990 to 2019: Results from the global burden of disease study 2019.1990 年至 2019 年与年龄相关的黄斑变性疾病负担的趋势和差异:2019 年全球疾病负担研究的结果。
Front Public Health. 2023 Apr 17;11:1138428. doi: 10.3389/fpubh.2023.1138428. eCollection 2023.
9
Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990-2019: results from the global burden of disease study 2019.1990 年至 2019 年 137 个中低收入国家慢性肾脏病负担及其归因风险负担:来自 2019 年全球疾病负担研究的结果。
BMC Nephrol. 2022 Jan 5;23(1):17. doi: 10.1186/s12882-021-02597-3.
10
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、地区和国家残疾调整生命年(DALYs)359 种疾病和伤害以及 195 个国家和地区 1990-2017 年的健康期望寿命(HALE):2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3.

本文引用的文献

1
Upper normal serum magnesium is associated with a reduction in incident death from fatal heart failure, coronary heart disease and stroke in non-dialysis patients with CKD stages 4 and 5.在慢性肾脏病4期和5期的非透析患者中,血清镁正常上限与致命性心力衰竭、冠心病和中风导致的死亡风险降低相关。
Clin Kidney J. 2024 Dec 2;18(2):sfae390. doi: 10.1093/ckj/sfae390. eCollection 2025 Feb.
2
Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies.心肾综合征:临床诊断、分子机制及治疗策略
Acta Pharmacol Sin. 2025 Feb 5. doi: 10.1038/s41401-025-01476-z.
3
Inflammation-based scores predict chronic kidney disease progression in patients with chronic kidney disease and chronic heart failure.
基于炎症的评分可预测慢性肾脏病合并慢性心力衰竭患者的慢性肾脏病进展。
Ren Fail. 2024 Dec;46(2):2432541. doi: 10.1080/0886022X.2024.2432541. Epub 2024 Nov 26.
4
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
5
Burden of heart failure in Asia, 1990-2019: findings from the Global Burden of Disease Study 2019.1990 - 2019年亚洲心力衰竭负担:全球疾病负担研究2019的结果
Public Health. 2024 May;230:66-72. doi: 10.1016/j.puhe.2024.02.015. Epub 2024 Mar 19.
6
Bioinformatics analysis of the microRNA genes associated with type 2 cardiorenal syndrome.miRNA 基因与 2 型心肾综合征相关性的生物信息学分析。
BMC Cardiovasc Disord. 2024 Mar 5;24(1):142. doi: 10.1186/s12872-024-03816-z.
7
Global, regional, and national burden of type 1 diabetes in adolescents and young adults.全球、区域和国家青少年及青年1型糖尿病负担
Pediatr Res. 2025 Feb;97(2):568-576. doi: 10.1038/s41390-024-03107-5. Epub 2024 Mar 5.
8
From heart failure and kidney dysfunction to cardiorenal syndrome: TMAO may be a bridge.从心力衰竭和肾功能不全到心肾综合征:氧化三甲胺可能是一座桥梁。
Front Pharmacol. 2023 Nov 21;14:1291922. doi: 10.3389/fphar.2023.1291922. eCollection 2023.
9
Safety and Performance of the Aortix Device in Acute Decompensated Heart Failure and Cardiorenal Syndrome.Aortix装置在急性失代偿性心力衰竭和心肾综合征中的安全性与性能
JACC Heart Fail. 2023 Nov;11(11):1565-1575. doi: 10.1016/j.jchf.2023.06.018. Epub 2023 Oct 4.
10
Disease Burden and Epidemiological Trends of Chronic Kidney Disease at the Global, Regional, National Levels from 1990 to 2019.1990 年至 2019 年全球、区域、国家各级别慢性肾脏病的疾病负担与流行病学趋势。
Nephron. 2024;148(2):113-123. doi: 10.1159/000534071. Epub 2023 Sep 15.